Profound Medical Corp's stock is making waves on the TSX, surging over 5% in a single trading session.
Profound Medical Corp (PRN.TO) is experiencing a significant uptick in its stock price today, gaining 5.87% to close at CA$9.74. This surge reflects growing investor confidence in the company’s recent financial performance and strategic initiatives.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeAdvertisement
Market cap
$334.31M
52W high
$12.40
52W low
$5.23
1W change
-9.80%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 172.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+172.1% Upside
Current Price
C$9.20
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
60.3%
Annualized
90-Day Vol
54.2%
Annualized
Trend (90d)
-15.7%
Annualized drift
90d Mean
C$8.70
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.03 | C$7.33 – C$11.12 |
| 60 trading days | C$8.86 | C$6.61 – C$11.89 |
| 90 trading days | C$8.70 | C$6.07 – C$12.47 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors are responding positively to Profound Medical's strong financial results and strategic fundraising efforts, indicating a bullish sentiment in the market.
Profound Medical Corp Gains 5.87% in One Day
The stock's market cap has reached CA$334 million, reflecting strong investor interest amid promising financial results.
Bull case
Profound Medical recently reported an impressive 104% revenue growth for Q1 2026, which has certainly caught the attention of investors. The successful closure of a $36 million offering also signals strong operational performance and financial health, likely boosting further interest from investors.
Bear case
However, despite this positive momentum, there are concerns about the long-term sustainability of this growth due to a lack of consistent profitability, as shown by a negative profit margin. This could raise questions for some investors about the company's future performance.
Advertisement
Strong Financial Performance
Profound Medical recently reported a staggering 104% revenue growth for Q1 2026, which has undoubtedly captured the attention of investors. This impressive performance, coupled with the coverage of the TULSA Procedure™ by Humana, positions the company favorably in the medical technology sector.
Strategic Fundraising Initiatives
The company has successfully closed a $36 million registered direct offering, which is expected to bolster its financial standing and support ongoing growth initiatives. Such strategic moves are likely contributing to the positive market sentiment surrounding PRN.TO.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
